Healthcare provider profile · identity verified

Mark Alan Dodd, DO

Family Practice · MOUNT AIRY, NC · NPI 1184694630

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	641	155
Levothyroxine Sodium	Levothyroxine Sodium	473	108
Amlodipine Besylate	Amlodipine Besylate	430	110
Metoprolol Succinate	Metoprolol Succinate	348	89
Simvastatin	Simvastatin	342	85
Hydrochlorothiazide	Hydrochlorothiazide	337	87
Losartan Potassium	Losartan Potassium	332	87
Lisinopril	Lisinopril	327	81
Omeprazole	Omeprazole	319	86
Pantoprazole Sodium	Pantoprazole Sodium	265	66
Gabapentin	Gabapentin	257	58
Montelukast Sodium	Montelukast Sodium	253	58
Sertraline Hcl	Sertraline Hcl	241	51
Metformin Hcl	Metformin Hcl	233	54
Metformin Hcl Er	Metformin Hcl	212	51
Pravastatin Sodium	Pravastatin Sodium	208	58
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	207	39
Rosuvastatin Calcium	Rosuvastatin Calcium	194	57
Furosemide	Furosemide	190	55
Duloxetine Hcl	Duloxetine Hcl	189	39
Jardiance	Empagliflozin	173	25
Escitalopram Oxalate	Escitalopram Oxalate	167	36
Allopurinol	Allopurinol	164	38
Lorazepam	Lorazepam	152	33
Valsartan	Valsartan	152	35
Albuterol Sulfate Hfa	Albuterol Sulfate	142	30
Fluticasone Propionate	Fluticasone Propionate	131	43
Potassium Chloride	Potassium Chloride	131	37
Eliquis	Apixaban	118	29
Chlorthalidone	Chlorthalidone	114	24
Metoprolol Tartrate	Metoprolol Tartrate	114	27
Citalopram Hbr	Citalopram Hydrobromide	111	30
Tamsulosin Hcl	Tamsulosin Hcl	109	28
Alprazolam	Alprazolam	108	18
Trazodone Hcl	Trazodone Hcl	94	18
Alendronate Sodium	Alendronate Sodium	91	17
Clonazepam	Clonazepam	90	17
Bupropion Xl	Bupropion Hcl	88	18
Fluoxetine Hcl	Fluoxetine Hcl	87	27
Meloxicam	Meloxicam	84	22
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	83	17
Pioglitazone Hcl	Pioglitazone Hcl	83	25
Carvedilol	Carvedilol	81	23
Glipizide	Glipizide	80	17
Tramadol Hcl	Tramadol Hcl	79	26
Ozempic	Semaglutide	77	16
Celecoxib	Celecoxib	76	18
Clopidogrel	Clopidogrel Bisulfate	74	17
Prednisone	Prednisone	74	42
Xarelto	Rivaroxaban	70	13
Glipizide Er	Glipizide	68	17
Atenolol	Atenolol	66	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	65	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	61	14
Venlafaxine Hcl Er	Venlafaxine Hcl	61	13
Famotidine	Famotidine	60	18
Enalapril Maleate	Enalapril Maleate	59	15
Glimepiride	Glimepiride	58	20
Zolpidem Tartrate	Zolpidem Tartrate	58	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	53	14
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	53	suppressed
Pregabalin	Pregabalin	52	suppressed
Benazepril Hcl	Benazepril Hcl	51	16
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	51	suppressed
Buspirone Hcl	Buspirone Hcl	50	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	50	11
Trulicity	Dulaglutide	50	suppressed
Finasteride	Finasteride	47	12
Lamotrigine	Lamotrigine	47	suppressed
Donepezil Hcl	Donepezil Hcl	44	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	44	suppressed
Ezetimibe	Ezetimibe	43	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	42	suppressed
Amoxicillin	Amoxicillin	39	30
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	38	suppressed
Spiriva Handihaler	Tiotropium Bromide	38	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	37	11
Oxycodone Hcl	Oxycodone Hcl	37	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	36	32
Colchicine	Colchicine	35	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	35	suppressed
Diazepam	Diazepam	34	suppressed
Warfarin Sodium	Warfarin Sodium	34	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	33	11
Ropinirole Hcl	Ropinirole Hcl	33	suppressed
Tizanidine Hcl	Tizanidine Hcl	33	19
Symbicort	Budesonide/Formoterol Fumarate	32	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	32	20
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	30	suppressed
Ventolin Hfa	Albuterol Sulfate	30	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	29	12
Cephalexin	Cephalexin	27	14
Doxycycline Hyclate	Doxycycline Hyclate	27	22
Nystatin	Nystatin	27	21
Paroxetine Hcl	Paroxetine Hcl	27	suppressed
Fluconazole	Fluconazole	26	20
Propranolol Hcl Er	Propranolol Hcl	26	suppressed
Lovastatin	Lovastatin	25	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	25	suppressed
Diclofenac Sodium	Diclofenac Sodium	24	suppressed
Hydralazine Hcl	Hydralazine Hcl	24	suppressed
Lansoprazole	Lansoprazole	24	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	23	suppressed
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	23	suppressed
Primidone	Primidone	23	suppressed
Risperidone	Risperidone	23	suppressed
Synthroid	Levothyroxine Sodium	23	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	22	suppressed
Propranolol Hcl	Propranolol Hcl	22	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	22	suppressed
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Dilantin	Phenytoin Sodium Extended	20	suppressed
Memantine Hcl	Memantine Hcl	20	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	20	20
Terazosin Hcl	Terazosin Hcl	20	suppressed
Acyclovir	Acyclovir	19	suppressed
Bumetanide	Bumetanide	19	suppressed
Lidocaine	Lidocaine	19	suppressed
Ondansetron Hcl	Ondansetron Hcl	19	11
Arexvy	Rsvpref3 Antigen/As01e/Pf	17	17
Digoxin	Digoxin	17	suppressed
Mupirocin	Mupirocin	17	suppressed
Verapamil Er	Verapamil Hcl	17	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	16	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Dutasteride	Dutasteride	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Linzess	Linaclotide	14	suppressed
Nebivolol Hcl	Nebivolol Hcl	14	suppressed
Olanzapine	Olanzapine	14	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Promethazine Hcl	Promethazine Hcl	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	12
Azelastine Hcl	Azelastine Hcl	12	suppressed
Azithromycin	Azithromycin	12	12
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Labetalol Hcl	Labetalol Hcl	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	11
Nystop	Nystatin	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Sodium Citrate-Citric Acid	Citric Acid/Sodium Citrate	12	suppressed
Topiramate	Topiramate	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Mounjaro	Tirzepatide	11	suppressed
Zafirlukast	Zafirlukast	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error